The company obtained market exclusivity for 180 days for Finasteride 1mg tablets in the country.
Finasteride tablet is the bioequivalent generic version of Propecia tablets, a prescription medicine used for the treatment of male pattern hair loss (androgenetic alopecia).
Propecia, which is a registered trademark of Merck Sharp & Dohme, a subsidiary of Merck, is said to block the formation of Dihydrotestosterone in the scalp thereby inhibiting further shrinkage of affected hair follicles.